AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7742151 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin
Number of subjects: 24
Study 2036922 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide administered intravenously every 8 hours until solid food diet tolerated
Number of subjects: 93
Study 2036922 — intervention group
Group type: COMPARATOR
Intervention: No metoclopramide (Control Group)
Number of subjects: 93
Study 7091898 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous cough while at rest (control)
Number of subjects: 6
Study 7091898 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural drainage
Number of subjects: 6
Study 7091898 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural drainage plus mechanical percussion
Number of subjects: 6
Study 7091898 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined maneuvers (postural drainage, deep breathing with vibrations, and percussion) administered by a physiotherapist
Number of subjects: 6
Study 7091898 — intervention group
Group type: EXPERIMENTAL
Intervention: Directed vigorous cough
Number of subjects: 6
Study 30957867 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention (WBI)
Number of subjects: 118
Study 30957867 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 118
Study 31091129 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic transtibial pull‐out root repair
Number of subjects: 10
Study 31091129 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic transtibial pull‐out root repair with centralization
Number of subjects: 10
Study 31091129 — intervention group
Group type: COMPARATOR
Intervention: Nonanatomic transtibial pull‐out repair
Number of subjects: 10
Study 31091129 — intervention group
Group type: COMPARATOR
Intervention: Nonanatomic transtibial pull‐out repair with centralization
Number of subjects: 10
Study 31091129 — intervention group
Group type: COMPARATOR
Intervention: Intact state
Number of subjects: 10
Study 31091129 — intervention group
Group type: EXPERIMENTAL
Intervention: Loaded knees at 90° flexion
Number of subjects: 10
Study 31091129 — intervention group
Group type: COMPARATOR
Intervention: Unloaded knees at full extension
Number of subjects: 10
Study 29017481 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group therapy (STEpS)
Number of subjects: 76
Study 29017481 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 76
Study 25910804 — intervention group
Group type: EXPERIMENTAL
Intervention: SR-nitrite (80 mg, twice daily by mouth for 21 days)
Number of subjects: 18
Study 25910804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 23815634 — intervention group
Group type: COMPARATOR
Intervention: Unilateral stimulation (anodal-tDCS over non-dominant M1)
Number of subjects: 11
Study 23815634 — intervention group
Group type: COMPARATOR
Intervention: Bilateral stimulation (anodal-tDCS over non-dominant M1 and cathodal-tDCS over dominant M1)
Number of subjects: 11
Study 23815634 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham stimulation
Number of subjects: 11
Study 21543158 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise
Number of subjects: 60
Study 21543158 — intervention group
Group type: COMPARATOR
Intervention: Contact control
Number of subjects: 60
Study 19523212 — intervention group
Group type: EXPERIMENTAL
Intervention: multiple traffic light label
Number of subjects: 420
Study 19523212 — intervention group
Group type: COMPARATOR
Intervention: no label
Number of subjects: 420
Study 17970675 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy during gestation
Number of subjects: 200
Study 17970675 — intervention group
Group type: COMPARATOR
Intervention: Control group (periodontal treatment after delivery)
Number of subjects: 200
Study 15496697 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 2-4 mg
Number of subjects: 0
Study 15496697 — intervention group
Group type: COMPARATOR
Intervention: Etomidate 0.2-0.3 mg/kg
Number of subjects: 0
Study 11563998 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole (20 mg)
Number of subjects: 328
Study 11563998 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole (20 mg)
Number of subjects: 328
Study 9729670 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt fluoridation (350 ppm F-/kg)
Number of subjects: 108
Study 9729670 — intervention group
Group type: COMPARATOR
Intervention: Non-salt fluoridation (Control)
Number of subjects: 108
Study 8065835 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose surfactant (200 mg/kg, max 600 mg/kg)
Number of subjects: 25
Study 8065835 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose surfactant (100 mg/kg, max 300 mg/kg)
Number of subjects: 25
Study 8065835 — intervention group
Group type: COMPARATOR
Intervention: Healthy comparison group (8 infants)
Number of subjects: 25
Study 8065835 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment schedules (high-dose and low-dose)
Number of subjects: 25
Study 2848652 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetate (15 mmol every 15 min)
Number of subjects: 5
Study 2848652 — intervention group
Group type: COMPARATOR
Intervention: Chloride (as control)
Number of subjects: 5
Study 29278019 — intervention group
Group type: EXPERIMENTAL
Intervention: ReaDySpeech with usual care (n=26)
Number of subjects: 40
Study 29278019 — intervention group
Group type: COMPARATOR
Intervention: Usual care only (n=14)
Number of subjects: 40
Study 27109827 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (Zytiga)
Number of subjects: 119
Study 25703887 — intervention group
Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 2059
Study 23972693 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher-delivered, brief, personality-targeted interventions (two 90-minute, CBT-based group interventions)
Number of subjects: 1024
Study 23972693 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher-delivered, brief, personality-targeted interventions
Number of subjects: 1024
Study 20587823 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intention intervention
Number of subjects: 77
Study 20587823 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 77
Study 18696157 — intervention group
Group type: EXPERIMENTAL
Intervention: Scintigraphic appearance time (SAT) >30 min
Number of subjects: 194
Study 18696157 — intervention group
Group type: EXPERIMENTAL
Intervention: Scintigraphic appearance time (SAT)
Number of subjects: 194
Study 28049190 — intervention group
Group type: COMPARATOR
Intervention: <sup>131</sup>I treatment
Number of subjects: 217
Study 28049190 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone treatment in combination with <sup>131</sup>I treatment
Number of subjects: 217
Study 28049190 — intervention group
Group type: EXPERIMENTAL
Intervention: RTX in combination with <sup>131</sup>I treatment
Number of subjects: 217
Study 12777589 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 200 micro g/d (max 400 micro g/d if uncontrolled)
Number of subjects: 174
Study 12777589 — intervention group
Group type: COMPARATOR
Intervention: Nedocromil sodium (NS) 8 mg/d (max 16 mg/d if uncontrolled)
Number of subjects: 174
Study 12777589 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 174
Study 12777589 — intervention group
Group type: COMPARATOR
Intervention: Nedocromil sodium (NS)
Number of subjects: 174
Study 11127339 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice powder salt solution and milk-rice mixture (RPSS-MR group, n = 17)
Number of subjects: 48
Study 11127339 — intervention group
Group type: COMPARATOR
Intervention: Glucose-based oral rehydration solution combined with milk-rice mixture (ORS-MR group, n = 17)
Number of subjects: 48
Study 11127339 — intervention group
Group type: COMPARATOR
Intervention: Glucose-based oral rehydration solution combined with formula milk (ORS-milk group, n = 14)
Number of subjects: 48
Study 9127460 — intervention group
Group type: EXPERIMENTAL
Intervention: Competitive one‐step enzyme‐linked immunosorbent assay (ELISA) using MAbA7
Number of subjects: 114
Study 9127460 — intervention group
Group type: COMPARATOR
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 114
Study 9127460 — intervention group
Group type: COMPARATOR
Intervention: Bisphosphonate therapy
Number of subjects: 114
Study 8420740 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole
Number of subjects: 11
Study 8420740 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 3532756 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine plus diet
Number of subjects: 3806
Study 3532756 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus diet
Number of subjects: 3806
Study 3532756 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic use
Number of subjects: 3806
Study 29635304 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist referrals (n = 255)
Number of subjects: 32
Study 29635304 — intervention group
Group type: COMPARATOR
Intervention: Free-text referrals (n = 256)
Number of subjects: 32
Study 29635304 — intervention group
Group type: EXPERIMENTAL
Intervention: All letters combined (n = 511)
Number of subjects: 32
Study 27336314 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive ceftriaxone
Number of subjects: 836
Study 27336314 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 836
Study 25255587 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate juice supplementation
Number of subjects: 28
Study 25255587 — intervention group
Group type: COMPARATOR
Intervention: Control (tap water)
Number of subjects: 28
Study 22715155 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid infusion
Number of subjects: 10
Study 22715155 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 10
Study 21232203 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthesia
Number of subjects: 297
Study 21232203 — intervention group
Group type: COMPARATOR
Intervention: General and spinal anesthesia
Number of subjects: 297
Study 18430217 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-time Boston brace wear
Number of subjects: 100
Study 18430217 — intervention group
Group type: COMPARATOR
Intervention: No bracing (Control)
Number of subjects: 100
Study 15753264 — intervention group
Group type: EXPERIMENTAL
Intervention: Planet Health obesity prevention program
Number of subjects: 480
Study 15753264 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 480
Study 12835602 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition-specific measures of quality of life preceding generic instruments
Number of subjects: 62
Study 12835602 — intervention group
Group type: COMPARATOR
Intervention: Generic instruments preceding condition-specific measures of quality of life
Number of subjects: 62
Study 11109042 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy
Number of subjects: 180000
Study 8872598 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults (71 y and older)
Number of subjects: 38
Study 8872598 — intervention group
Group type: COMPARATOR
Intervention: Middle-aged men (37-52 y)
Number of subjects: 38
Study 8872598 — intervention group
Group type: EXPERIMENTAL
Intervention: Older men (79 y+)
Number of subjects: 38
Study 8872598 — intervention group
Group type: EXPERIMENTAL
Intervention: Older women (79 y+)
Number of subjects: 38
Study 8872598 — intervention group
Group type: COMPARATOR
Intervention: Young controls (19-28 y)
Number of subjects: 38
Study 1320550 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-component model for body composition assessment
Number of subjects: 28
Study 1320550 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-component model for body composition assessment
Number of subjects: 28
Study 1320550 — intervention group
Group type: EXPERIMENTAL
Intervention: Deuterium dilution method
Number of subjects: 28
Study 1320550 — intervention group
Group type: EXPERIMENTAL
Intervention: Densitometry method
Number of subjects: 28
Study 1320550 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydration fraction of fat-free mass
Number of subjects: 28
Study 1320550 — intervention group
Group type: EXPERIMENTAL
Intervention: Density of fat-free mass
Number of subjects: 28
Study 6372924 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine
Number of subjects: 0
Study 6372924 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29462033 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous low-dose epinephrine plus tranexamic acid
Number of subjects: 179
Study 29462033 — intervention group
Group type: COMPARATOR
Intervention: Topical diluted epinephrine plus tranexamic acid
Number of subjects: 179
Study 29462033 — intervention group
Group type: COMPARATOR
Intervention: Tranexamic acid alone
Number of subjects: 179
Study 27282230 — intervention group
Group type: EXPERIMENTAL
Intervention: True Positive (TP) alerts
Number of subjects: 66
Study 27282230 — intervention group
Group type: EXPERIMENTAL
Intervention: False Positive (FP) alerts
Number of subjects: 66
Study 27282230 — intervention group
Group type: COMPARATOR
Intervention: TP and FP alerts mixed
Number of subjects: 66
Study 24343823 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH) for 72 hours, maintaining rectal temperature at 33-34°C
Number of subjects: 0
Study 24343823 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH)
Number of subjects: 0
Study 24343823 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hypothermia)
Number of subjects: 0
Study 22252782 — intervention group
Group type: COMPARATOR
Intervention: Normal faces
Number of subjects: 40
Study 22252782 — intervention group
Group type: EXPERIMENTAL
Intervention: Paralyzed faces
Number of subjects: 40
Study 22252782 — intervention group
Group type: EXPERIMENTAL
Intervention: Smiling (Normal faces)
Number of subjects: 40
Study 22252782 — intervention group
Group type: EXPERIMENTAL
Intervention: Smiling (Paralyzed faces)
Number of subjects: 40
Study 19627552 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose breast milk
Number of subjects: 142
Study 19627552 — intervention group
Group type: COMPARATOR
Intervention: Single-dose sterile water
Number of subjects: 142
Study 19627552 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose 12.5% sucrose
Number of subjects: 142
Study 19627552 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses breast milk
Number of subjects: 142
Study 19627552 — intervention group
Group type: COMPARATOR
Intervention: Two doses sterile water
Number of subjects: 142
Study 19627552 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses 12.5% sucrose
Number of subjects: 142
Study 18556852 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message service (SMS) via mobile phone for prenatal support (2 messages per week from 28 weeks of gestation until giving birth)
Number of subjects: 68
Study 18556852 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message service (SMS) via mobile phone for prenatal support
Number of subjects: 68
Study 18556852 — intervention group
Group type: COMPARATOR
Intervention: General antenatal care (control group)
Number of subjects: 68
Study 16091266 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconscious priming with repeated visual displays
Number of subjects: 0
Study 16091266 — intervention group
Group type: COMPARATOR
Intervention: Unconscious priming with new visual displays
Number of subjects: 0
Study 11929799 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral valacyclovir (2 g) 4 times daily until week 18 after transplantation
Number of subjects: 727
Study 11929799 — intervention group
Group type: COMPARATOR
Intervention: Oral acyclovir (800 mg) 4 times daily until week 18 after transplantation
Number of subjects: 727
Study 11929799 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir
Number of subjects: 727
Study 11929799 — intervention group
Group type: COMPARATOR
Intervention: Acyclovir
Number of subjects: 727
Study 11929799 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir and Acyclovir
Number of subjects: 727
Study 9448771 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory stimuli (pyridine, menthone, amyl acetate)
Number of subjects: 8
Study 9448771 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects (control group)
Number of subjects: 8
Study 8546282 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal pethidine hydrochloride 0.50 mg.kg‐1
Number of subjects: 0
Study 8546282 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal pethidine hydrochloride 0.75 mg.kg‐1
Number of subjects: 0
Study 8546282 — intervention group
Group type: COMPARATOR
Intervention: Isobaric bupivacaine 13.75 mg
Number of subjects: 0
Study 2468931 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal administration of synthetic human natriuretic peptide (4‐28 hANP) at doses of 50, 100, 200, and 500 micrograms.
Number of subjects: 6
Study 2468931 — intervention group
Group type: COMPARATOR
Intervention: Vehicle administered randomly between doses of hANP.
Number of subjects: 6
Study 14651 — intervention group
Group type: EXPERIMENTAL
Intervention: carpipramine
Number of subjects: 30
Study 14651 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 29343088 — intervention group
Group type: EXPERIMENTAL
Intervention: Promotion messages (e.g., 'Live your best life - Take your medications')
Number of subjects: 20
Study 29343088 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention messages (e.g., 'team up with your provider to create a combination of medications to prevent illness')
Number of subjects: 20
Study 27397061 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with fenofibrate (200 mg/day or 160 mg/day) and ezetimibe (10 mg/day)
Number of subjects: 236
Study 27397061 — intervention group
Group type: COMPARATOR
Intervention: Fenofibrate monotherapy
Number of subjects: 236
Study 27397061 — intervention group
Group type: COMPARATOR
Intervention: Ezetimibe monotherapy
Number of subjects: 236
Study 27397061 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with fenofibrate and ezetimibe
Number of subjects: 236
Study 25644328 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 205
Study 23224354 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline (75 mg intravenous)
Number of subjects: 300
Study 23224354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 20880999 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 200 mg/m² plus gemcitabine 1 gm/m² (group A) on days 1 and 8 every 3 weeks
Number of subjects: 398
Study 20880999 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel 80 mg/m² plus vinorelbine 22.5 mg/m² (group B) on days 1, 8 and 15 every 4 weeks
Number of subjects: 398
Study 19905891 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine once-daily
Number of subjects: 973
Study 19905891 — intervention group
Group type: COMPARATOR
Intervention: Insulin detemir twice-daily
Number of subjects: 973
Study 19905891 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine once-daily and Insulin detemir twice-daily
Number of subjects: 973
Study 16846400 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20-mg taken 'as needed'
Number of subjects: 132
Study 16846400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 10364907 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone
Number of subjects: 10
Study 10364907 — intervention group
Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 10
Study 9012182 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated humidifier (HC 100, company Fisher & Paykel)
Number of subjects: 13
Study 9012182 — intervention group
Group type: COMPARATOR
Intervention: Heat and moisture exchanger (Typ I, company Dahlhausen)
Number of subjects: 13
Study 1991906 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 18
Study 1991906 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 18
Study 1991906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 6347118 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (125 mg/day for 7 days, then 250 mg/day for 36 weeks)
Number of subjects: 82
Study 6347118 — intervention group
Group type: COMPARATOR
Intervention: Placebo and methadone
Number of subjects: 82
Study 31798025 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized orthopaedic shoes (experimental group)
Number of subjects: 73
Study 31798025 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 73
Study 29853841 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention (MTSZ) for 1 month
Number of subjects: 0
Study 29853841 — intervention group
Group type: COMPARATOR
Intervention: Non-music intervention (UMTSZ) for 1 month
Number of subjects: 0
Study 25545549 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% mometasone furoate hydrogel (test)
Number of subjects: 90
Study 25545549 — intervention group
Group type: COMPARATOR
Intervention: 0.1% mometasone furoate lotion (reference)
Number of subjects: 90
Study 24668526 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated detection and quantification of malapposed struts at baseline
Number of subjects: 64
Study 24668526 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated detection and quantification of uncovered struts at follow-up
Number of subjects: 64
Study 22169682 — intervention group
Group type: EXPERIMENTAL
Intervention: Xience V (everolimus-eluting stent)
Number of subjects: 140
Study 22169682 — intervention group
Group type: COMPARATOR
Intervention: Vision (bare-metal stent)
Number of subjects: 140
Study 20576744 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS intervention group
Number of subjects: 120
Study 20576744 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 20576744 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 120
Study 20576744 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 17116159 — intervention group
Group type: COMPARATOR
Intervention: 0.2% delmopinol mouth rinse
Number of subjects: 1380
Study 16253066 — intervention group
Group type: EXPERIMENTAL
Intervention: Bard Inlay stent
Number of subjects: 44
Study 16253066 — intervention group
Group type: COMPARATOR
Intervention: Vertex stent
Number of subjects: 44